전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화

논문상세정보
' 전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • benignprostatehyperplasia
  • bph-inducedrat
  • curcumalongal.
  • pro-inflammatory cytokines
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
68 0

0.0%

' 전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화' 의 참고문헌

  • Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
    Shin IS Food Chem Toxicol 50 : 884 ~ 888 [2012]
  • The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia(BPH)
    Gandaglia G BJU Int 112 : 432 ~ 441 [2013]
  • The effect of turmeric(Curcuma longa)extract on the functionality of the solute carrier protein 22 A4(SLC22A4)and interleukin-10(IL-10)variants associated with inflammatory bowel disease
    McCann MJ Nutrients 6 : 4178 ~ 4190 [2014]
  • The de-velopment of human benign prostatic hyperplasia with age
    Berry SJ J Urol 132 : 474 ~ 479 [1984]
  • TNF/IL-1/NIK/NF-κB transduction pathway : A comparative study in normal and pathological human pro-state(benign hyperplasia and carcinoma)
    Nuñez C Histopathology 53 : 166 ~ 176 [2008]
  • Serenoa repens, lyco-pene and selenium : A triple therapeutic approach to manage benign prostatic hyperplasia
    Minutoli L Curr Med Chem 20 : 1306 ~ 1312 [2013]
  • Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and che-moprevention-A mechanistic approach
    Sikka SC Curr Med Chem 10 : 2679 ~ 2692 [2003]
  • Prostate development and growth in benign prostatic hyperplasia
    Timms BG Differentiation 82 : 173 ~ 183 [2011]
  • Pathology of benign prostatic hyper- plasia
    Roehrborn CG Int J Impotence Res 20 : 11 ~ 18 [2008]
  • Oxidative stress in patients with benign prostate hyperplasia
    Aryal M J Nepal Med Assoc 46 : 103 ~ 106 [2007]
  • Molecular link me-chanisms between inflammation and cancer
    Vendramini-Costa DB Curr Pharm Des 18 : 3831 ~ 3852 [2012]
  • Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia : Emphasis on PTEN, HIF-1α, and NF-κB
    Atawia RT Naunyn Schmiedebergs Arch Pharmacol 387 : 1131 ~ 1140 [2014]
  • Immunomodulatory effect of red onion(Allium cepa Linn)scale extract on ex-perimentally induced atypical prostatic hyperplasia in Wistar rats
    Elberry AA Mediators Inflamm 640746 [2014]
  • Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompa- nying chronic inflammation
    Park DS Urol Int 81 : 441 ~ 446 [2008]
  • Evaluation of oxidative stress and DNA damage in benign prostatic hyperplasia patients and comparison with controls
    Ahmad M Indian J Clin Biochem 27 : 385 ~ 388 [2012]
  • Effects of hexanic extract of serenoa repens(permi-xon® 160 mg)on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
    Latil A Prostate 75 : 1857 ~ 1867 [2015]
  • Effect of curcumin (Curcuma longa extract) on LPS- induced acute lung injury is mediated by the activation of AMPK
    Kim J J Anesth 3 [2015]
  • Could inflammation be a key component in the progression of benign prostatic hyperpla-sia?
    Kramer G Curr Opin Urol 16 : 25 ~ 29 [2006]
  • Correlation between benign prostatic hyperplasia and infla-mmation
    Bostanci Y Curr Opin Urol 23 : 5 ~ 10 [2013]
  • Antiobesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes
    Ho JN J Sci Food Agric 92 : 1833 ~ 1840 [2012]
  • Anti-inflammatory properties of lipidosterolic extract of Serenoa repens(Permixon®)in a mouse model of prostate hyperplasia
    Bernichtein S Prostate 75 : 706 ~ 722 [2015]
  • Anti-inflammatory and antiproliferative activities of date palm pollen(Phoenix dactylifera)on experimentally-induced atypical prostatic hyperplasia in rats
    Elberry AA J Inflamm(Lond) 8 : 40 ~ 53 [2011]
  • Anti-Inflammatory activity of polysaccharide fraction of Cur-cuma longa extract(NR-INF-02)
    Illuri R Antiinflamm Antiallergy Agents Med Chem 14 : 53 ~ 62 [2015]